WallStSmart

EUDA Health Holdings Limited (EUDA)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 209927% more annual revenue ($10.84B vs $5.16M). WELL leads profitability with a 8.6% profit margin vs 5.2%. EUDA trades at a lower P/E of 26.6x. WELL earns a higher WallStSmart Score of 39/100 (F).

EUDA

Avoid

31

out of 100

Grade: F

Growth: 8.0Profit: 3.0Value: 5.3Quality: 5.8
Piotroski: 5/9

WELL

Hold

39

out of 100

Grade: F

Growth: 7.3Profit: 4.0Value: 2.0Quality: 6.5
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for EUDA.

WELLSignificantly Overvalued (-71.2%)

Margin of Safety

-71.2%

Fair Value

$121.42

Current Price

$212.09

$90.67 premium

UndervaluedFair: $121.42Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

EUDA2 strengths · Avg: 10.0/10
Revenue GrowthGrowth
60.2%10/10

Revenue surging 60.2% year-over-year

Debt/EquityHealth
-0.6210/10

Conservative balance sheet, low leverage

WELL2 strengths · Avg: 9.5/10
Revenue GrowthGrowth
41.3%10/10

Revenue surging 41.3% year-over-year

Market CapQuality
$147.07B9/10

Large-cap with strong market position

Areas to Watch

EUDA4 concerns · Avg: 3.5/10
P/E RatioValuation
26.6x4/10

Moderate valuation

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$20.08M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
0.0%3/10

ROE of 0.0% — below average capital efficiency

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
2.5%3/10

ROE of 2.5% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
147.0x2/10

Premium valuation, high expectations priced in

EPS GrowthGrowth
-26.3%2/10

Earnings declined 26.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : EUDA

The strongest argument for EUDA centers on Revenue Growth, Debt/Equity. Revenue growth of 60.2% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, Market Cap. Revenue growth of 41.3% demonstrates continued momentum.

Bear Case : EUDA

The primary concerns for EUDA are P/E Ratio, EPS Growth, Market Cap.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 147.0x leaves little room for execution misses.

Key Dynamics to Monitor

WELL carries more volatility with a beta of 0.82 — expect wider price swings.

EUDA is growing revenue faster at 60.2% — sustainability is the question.

WELL generates stronger free cash flow (647M), providing more financial flexibility.

Monitor REAL ESTATE SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

WELL scores higher overall (39/100 vs 31/100) and 41.3% revenue growth. Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

EUDA Health Holdings Limited

REAL ESTATE · REAL ESTATE SERVICES · USA

EUDA Health Holdings Limited is a biopharmaceutical innovator dedicated to the discovery, development, and commercialization of transformative therapies addressing rare diseases and unmet medical needs. Leveraging cutting-edge technologies and a robust clinical pipeline, the company focuses on pivotal areas such as supportive care and immune modulation. With a strong commitment to research and development, EUDA is poised to advance healthcare innovation and enhance patient outcomes, while striving to broaden access to essential medical therapies through its promising clinical initiatives.

Visit Website →

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?